PLK1 and sarcoma: Here, we assessed the concomitance of an efficient CPT-induced cell death and PLK1 downmodulation in a panel of SCC and pediatric sarcoma cell lines, and confirmed that PLK1 levels were not modulated in cells resistant to CPT-induced apoptosis.